The Proliferation Index of Erythroid Cells Predicts the Development of Transfusion-dependence in Myelodysplastic Syndrome Patients With Mildly Reduced Hemoglobin Levels at Initial Diagnosis

Overview

Journal Hemasphere

Publisher Wiley

Specialty Hematology

Date 2022 Nov 16

PMID 36382052

Authors

Stefan G C Mestrum

Norbert C J de Wit

Eline M P Cremers

Roosmarie J M Drent

Frans C S Ramaekers

Anton H N Hopman

Math P G Leers

Affiliations

Soon will be listed here.

Citing Articles

DeepHeme: A generalizable, bone marrow classifier with hematopathologist-level performance.

Goldgof G, Sun S, Van Cleave J, Wang L, Lucas F, Brown L bioRxiv. 2023; .

PMID: 36865216 PMC: 9979993. DOI: 10.1101/2023.02.20.528987.

References

Malcovati L, Della Porta M, Strupp C, Ambaglio I, Kuendgen A, Nachtkamp K . Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS). Haematologica. 2011; 96(10):1433-40. PMC: 3186303. DOI: 10.3324/haematol.2011.044602. View

Mei Y, Liu Y, Ji P . Understanding terminal erythropoiesis: An update on chromatin condensation, enucleation, and reticulocyte maturation. Blood Rev. 2020; 46:100740. DOI: 10.1016/j.blre.2020.100740. View

Greenberg P, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Sole F . Revised international prognostic scoring system for myelodysplastic syndromes. Blood. 2012; 120(12):2454-65. PMC: 4425443. DOI: 10.1182/blood-2012-03-420489. View

Mestrum S, Cremers E, de Wit N, Drent R, Ramaekers F, Hopman A . Optimized gating strategy and supporting flow cytometry data for the determination of the Ki-67 proliferation index in the diagnosis of myelodysplastic syndrome. Data Brief. 2022; 41:107976. PMC: 8891968. DOI: 10.1016/j.dib.2022.107976. View

de Swart L, Crouch S, Hoeks M, Smith A, Langemeijer S, Fenaux P . Impact of red blood cell transfusion dose density on progression-free survival in patients with lower-risk myelodysplastic syndromes. Haematologica. 2019; 105(3):632-639. PMC: 7049377. DOI: 10.3324/haematol.2018.212217. View

Cheson B, Greenberg P, Bennett J, Lowenberg B, Wijermans P, Nimer S . Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia. Blood. 2006; 108(2):419-25. DOI: 10.1182/blood-2005-10-4149. View

Hartmann J, Braulke F, Sinzig U, Wulf G, Maas J, Konietschke F . Iron overload impairs proliferation of erythroid progenitors cells (BFU-E) from patients with myelodysplastic syndromes. Leuk Res. 2012; 37(3):327-32. DOI: 10.1016/j.leukres.2012.11.005. View

Alhan C, Westers T, Cremers E, Cali C, Witte B, Ossenkoppele G . High flow cytometric scores identify adverse prognostic subgroups within the revised international prognostic scoring system for myelodysplastic syndromes. Br J Haematol. 2014; 167(1):100-9. DOI: 10.1111/bjh.12994. View

Wood E, McQuilten Z . Outpatient transfusions for myelodysplastic syndromes. Hematology Am Soc Hematol Educ Program. 2020; 2020(1):167-174. PMC: 7727529. DOI: 10.1182/hematology.2020000103. View

10.

Mestrum S, Vanblarcum R, Drent R, Boonen B, van Hemert W, Ramaekers F . Proliferative and anti-apoptotic fractions in maturing hematopoietic cell lineages and their role in homeostasis of normal bone marrow. Cytometry A. 2022; 101(7):552-563. PMC: 9540078. DOI: 10.1002/cyto.a.24558. View

11.

Mestrum S, de Wit N, Drent R, Hopman A, Ramaekers F, Leers M . Proliferative activity is disturbed in myeloproliferative neoplasms (MPN), myelodysplastic syndrome (MDS), and MDS/MPN diseases. Differences between MDS and MDS/MPN. Cytometry B Clin Cytom. 2020; 100(3):322-330. PMC: 8247351. DOI: 10.1002/cyto.b.21946. View

12.

Matarraz S, Teodosio C, Fernandez C, Albors M, Jara-Acevedo M, Lopez A . The proliferation index of specific bone marrow cell compartments from myelodysplastic syndromes is associated with the diagnostic and patient outcome. PLoS One. 2012; 7(8):e44321. PMC: 3432128. DOI: 10.1371/journal.pone.0044321. View

13.

Braga Lemos M, Rodrigues S, Schroeder T, Kulasekararaj A, Matos J, Tang D . Association between red blood cell transfusion dependence and burden in patients with myelodysplastic syndromes: A systematic literature review and meta-analysis. Eur J Haematol. 2021; 107(1):3-23. DOI: 10.1111/ejh.13619. View

14.

Thiagarajan P, Parker C, Prchal J . How Do Red Blood Cells Die?. Front Physiol. 2021; 12:655393. PMC: 8006275. DOI: 10.3389/fphys.2021.655393. View

15.

de Swart L, Smith A, Johnston T, Haase D, Droste J, Fenaux P . Validation of the revised international prognostic scoring system (IPSS-R) in patients with lower-risk myelodysplastic syndromes: a report from the prospective European LeukaemiaNet MDS (EUMDS) registry. Br J Haematol. 2015; 170(3):372-83. DOI: 10.1111/bjh.13450. View